Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
The renal hemodynamic effects of the SGLT2 inhibitor dapagliflozin are caused by post-glomerular vasodilatation rather than pre-glomerular vasoconstriction in metformin-treated patients with type 2 diabetes in the randomized, double-blind RED trial
PaperCitations, authors & open-access status
The renal hemodynamic effects of the SGLT2 inhibitor dapagliflozin are caused by post-glomerular vasodilatation rather than pre-glomerular vasoconstriction in metformin-treated patients with type 2 diabetes in the randomized, double-blind RED trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 350 citations, 2019 year and green oa status.
350
Citations
2019
Year
green
OA Status